DCGI Seeking More Data For Granting Emergency Use Authorisation Won’t Impact Timeline For Vaccine Roll-Out: Govt
New Delhi : The applications of Bharat Biotech, Serum Institute and Pfizer seeking emergency use authorisation for their COVID-19 vaccines are being examined, the Centre said on Tuesday asserting that drug…
CDSCO To Identify And Set Up Two Additional Facilities For Testing COVID-19 Vaccines
New Delhi : To expedite and regulate the testing of COVID-19 vaccine, the Central Drugs Standard Control Organisation (CDSCO) is in the process of putting a functioning mechanism in place. The…
NPPA extends revised ceiling price of Heparin Injection till March 2021
The National Pharmaceutical Pricing Authority (NPPA) has extended the revised ceiling price of Heparin Injection 5000IU/ml and 1000 IU/ml up to March 2021. The authority has taken the decision based…
SLAs Ask Mask Manufacturers To Expeditiously Register With CDSCO For Compliance
Mumbai : While the central government had allowed mask manufacturers to manufacture and then apply for registration within 18 months considering the ongoing pandemic, the state licensing authorities (SLAs) have…
SEC Asks DCGI To Dig Out Details About ‘Side-Effects’ Of HCQ
New Delhi : The Narendra Modi government has recommended to the Central Drugs Standard Control Organisation (CDSCO), the country’s apex health regulatory body, to find out more details about the…
Bharat biotech’s Covid-19 vaccine Covaxin gets DCGI nod for phase 3 clinical trial
New Delhi: The Drugs Controller General of India (DCGI) on Friday permitted Bharat Biotech to conduct phase 3 clinical trials of its indigenously developed Covid-19 vaccine with certain conditions, officials said. A subject expert committee on Covid-19 at…
Baxter India gets CDSCO Nod for Oxiris Filter to Treat COVID Patients
New Delhi: Baxter India has received approval from the Central Drugs Standard Control Organization (CDSCO) under Directorate General of Health Services, Ministry of Health & Family Welfare to use Oxiris…
Bharat Biotech’s COVAXIN gets DCGI approval for Phase I & II Human Clinical Trials
COVAXIN has been successfully developed by Bharat Biotech, a vaccine for COVID-19 by collaborating with the Indian Council of Medical Research (ICMR) – National Institute of Virology (NIV). The SARS-CoV-2…
Ban on Methylcobalamin to be revoked as FSSAI scientific panel approves Vitamin B12 as nutraceuticals
Industry finally heaves a sigh of relief as ban on manufacturing methylcobalamin in Gujarat would soon be revoked as Methylcobalamin (Vitamin B12) has been approved by the the Food Safety…
Ultrasound Machine becomes a Drug! Sounds like ‘Sex Change’
New Delhi: Ultrasound Machine will now be a Drug, a medicine! Sounds like sex change, doesn’t it? It is a ‘forced’ marriage of sorts. The draft notification issued by Union…
